688193 Stock Overview
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Shanghai Rendu Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥31.55 |
| 52 Week High | CN¥52.63 |
| 52 Week Low | CN¥22.50 |
| Beta | 0 |
| 1 Month Change | -3.69% |
| 3 Month Change | 3.82% |
| 1 Year Change | -26.34% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -51.28% |
Recent News & Updates
We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)
Apr 17
What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You
Mar 08Shareholder Returns
| 688193 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 5.0% | 3.4% | 1.2% |
| 1Y | -26.3% | -13.1% | -12.6% |
Return vs Industry: 688193 underperformed the CN Medical Equipment industry which returned -13.1% over the past year.
Return vs Market: 688193 underperformed the CN Market which returned -12.6% over the past year.
Price Volatility
| 688193 volatility | |
|---|---|
| 688193 Average Weekly Movement | 10.8% |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.0% |
Stable Share Price: 688193's share price has been volatile over the past 3 months.
Volatility Over Time: 688193's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 529 | Minghui Yu | www.rdbio.com |
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.
Shanghai Rendu Biotechnology Co., Ltd. Fundamentals Summary
| 688193 fundamental statistics | |
|---|---|
| Market cap | CN¥1.26b |
| Earnings (TTM) | CN¥18.36m |
| Revenue (TTM) | CN¥170.46m |
68.8x
P/E Ratio7.4x
P/S RatioIs 688193 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688193 income statement (TTM) | |
|---|---|
| Revenue | CN¥170.46m |
| Cost of Revenue | CN¥31.73m |
| Gross Profit | CN¥138.73m |
| Other Expenses | CN¥120.37m |
| Earnings | CN¥18.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 81.38% |
| Net Profit Margin | 10.77% |
| Debt/Equity Ratio | 0% |
How did 688193 perform over the long term?
See historical performance and comparison